Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Updates on PARP Inhibition

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

Featured Host
×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11690773
archived
Play
  • Host

In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Darren Hodgson, AstraZeneca presented updates on PARP inhibition. Topics include:

  • Strategies to target homologous recombination repair deficiency
  • Monotherapy indications and current development landscape
  • Scientific hypotheses being explored in olaparib combinations

To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled